Sumitomo Mitsui DS Asset Management Company Ltd Sells 1,491 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sumitomo Mitsui DS Asset Management Company Ltd trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 58,255 shares of the medical equipment provider’s stock after selling 1,491 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Intuitive Surgical were worth $30,407,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Bennett Selby Investments LP grew its stake in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares in the last quarter. LVW Advisors LLC lifted its position in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. lifted its position in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. FSM Wealth Advisors LLC lifted its position in shares of Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC lifted its position in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,940 shares of company stock valued at $3,333,485 over the last ninety days. Company insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on ISRG. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial raised their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $588.50 on Friday. The firm’s 50-day moving average is $553.03 and its two-hundred day moving average is $512.59. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $209.61 billion, a PE ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.